Report NEP-IND-2011-11-21
This is the archive for NEP-IND, a report on new working papers in the area of Industrial Organization. Kwang Soo Cheong issued this report. It is usually issued weekly.Subscribe to this report: email, RSS, or Mastodon, or Bluesky.
Other reports in NEP-IND
The following items were announced in this report:
- Bulow, Jeremy & Klemperer, Paul, 2011. "Price Controls and Consumer Surplus," Research Papers 2086, Stanford University, Graduate School of Business.
- Aguirre Pérez, Iñaki, 2011. "Multimarket Competition and Welfare Effects of Price discrimination," IKERLANAK 2011-55, Universidad del País Vasco - Departamento de Fundamentos del Análisis Económico I.
- Aguirre Pérez, Iñaki, 2011. "Welfare Effects of Third-Degree Price Discrimination: Ippolito Meets Schmalensee and Varian," IKERLANAK 2011-54, Universidad del País Vasco - Departamento de Fundamentos del Análisis Económico I.
- Wassim Daher & Fida Karam & Leonard J. Mirman, 2011. "Insider Trading with Different Market Structures," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) halshs-00639657, HAL.
- JP Eggers & Michal Grajek & Tobias Kretschmer, 2011. "Decomposing First Mover Advantages in the Mobile Telecommunications Industry," DRUID Working Papers 11-09, DRUID, Copenhagen Business School, Department of Industrial Economics and Strategy/Aalborg University, Department of Business Studies.
- Comanor, William S. & Scherer, F. M., 2011. "Mergers and Innovation in the Pharmaceutical Market," Working Paper Series rwp11-043, Harvard University, John F. Kennedy School of Government.
- Zhao, Tianshu & Matthews, Kent & Murinde, Victor, 2011. "Cross-Selling, Switching Costs and Imperfect Competition in British Banks," Cardiff Economics Working Papers E2011/29, Cardiff University, Cardiff Business School, Economics Section.
- Mainak Mazumdar & Meenakshi Rajeev & Subhash Ray, 2011. "Sources of Heterogeneity in the Efficiency of Indian Pharmaceutical Firms," Working papers 2011-22, University of Connecticut, Department of Economics.